Nuvilex rides the waves like the other bio's.....so don't be so sure about that...Biotech starts reporting next week....along with big tech companies...S&P 500...63% of co.'s reported have beaten estimates so far....and England does not seem to have a problem with Gilead's Sovaldi treatment price...they just bought $31M worth from them....